{"entity":{"type":"insider","cik":"0001509643","url":"/insider/0001509643","json_url":"/insider/0001509643.json","name":"THOMPSON JOHN CRAIG","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2011-08-24","last":"2017-09-20","span_basis":"filed_date"},"name_variants":[{"name":"THOMPSON JOHN CRAIG","source":"filing","n_filings":9,"first_seen":"2011-08-24","last_seen":"2017-09-20"}],"transactions":[{"id":4232384,"accession":"0001214659-17-005694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-17-005694","line_url":"/filing/0001214659-17-005694#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8550.0,"shares_display":"8,550","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":11286.0,"total_display":"11,286.00","total_whole":"11,286","shares_owned_after":19848.0,"shares_owned_after_display":"19,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-20","filed_date":"2017-09-20","scope":"insider"},{"id":9273484,"accession":"0001214659-17-005550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-17-005550","line_url":"/filing/0001214659-17-005550#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10400.0,"shares_display":"10,400","price_per_share":1.432,"price_display":"1.43","price_state":"stated","total_value":14892.8,"total_display":"14,892.80","total_whole":"14,893","shares_owned_after":11298.0,"shares_owned_after_display":"11,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-07","filed_date":"2017-09-07","scope":"insider"},{"id":8676125,"accession":"0001209191-15-070267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-070267","line_url":"/filing/0001209191-15-070267#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":44.08,"price_display":"44.08","price_state":"stated","total_value":440800.0,"total_display":"440,800.00","total_whole":"440,800","shares_owned_after":343.0,"shares_owned_after_display":"343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-10","scope":"insider"},{"id":8812618,"accession":"0001209191-15-064734","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-064734","line_url":"/filing/0001209191-15-064734#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":46.31,"price_display":"46.31","price_state":"stated","total_value":463100.0,"total_display":"463,100.00","total_whole":"463,100","shares_owned_after":343.0,"shares_owned_after_display":"343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-05","filed_date":"2015-08-07","scope":"insider"},{"id":8374914,"accession":"0001209191-15-060151","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-060151","line_url":"/filing/0001209191-15-060151#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":47.91,"price_display":"47.91","price_state":"stated","total_value":479100.0,"total_display":"479,100.00","total_whole":"479,100","shares_owned_after":343.0,"shares_owned_after_display":"343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-08","scope":"insider"},{"id":8253341,"accession":"0001209191-15-053992","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-053992","line_url":"/filing/0001209191-15-053992#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":41.51,"price_display":"41.51","price_state":"stated","total_value":415100.0,"total_display":"415,100.00","total_whole":"415,100","shares_owned_after":343.0,"shares_owned_after_display":"343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider"},{"id":8903659,"accession":"0001209191-15-052073","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-052073","line_url":"/filing/0001209191-15-052073","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22499.0,"shares_display":"22,499","price_per_share":43.26361171607627,"price_display":"43.26","price_state":"stated","total_value":973388.0,"total_display":"973,388.00","total_whole":"973,388","shares_owned_after":10980.0,"shares_owned_after_display":"10,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider","n_lines":2},{"id":8692790,"accession":"0001209191-15-044444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-044444","line_url":"/filing/0001209191-15-044444#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":39.63,"price_display":"39.63","price_state":"stated","total_value":1188900.0,"total_display":"1,188,900.00","total_whole":"1,188,900","shares_owned_after":343.0,"shares_owned_after_display":"343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-19","scope":"insider"},{"id":9093225,"accession":"0001181431-11-046728","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-046728","line_url":"/filing/0001181431-11-046728#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001509643","owner_name":"THOMPSON JOHN CRAIG","owner_display_name":"THOMPSON JOHN CRAIG","owner_url":"/insider/0001509643","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133.0,"shares_display":"133","price_per_share":6.48,"price_display":"6.48","price_state":"stated","total_value":861.84,"total_display":"861.84","total_whole":"862","shares_owned_after":133.0,"shares_owned_after_display":"133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-22","filed_date":"2011-08-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Director, Officer (President & CEO)","n_filings":2,"first_seen":"2017-09-07","last_seen":"2017-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Officer (Chief Operating Officer)","n_filings":6,"first_seen":"2015-05-19","last_seen":"2015-09-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Officer (Chief Commercial Officer)","n_filings":1,"first_seen":"2011-08-24","last_seen":"2011-08-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001509643","retrieved_at":"2026-08-23T04:43:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}